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Purpose: To describe the earliest features of ABCA4-associated retinopathy.
Design: Case series.
Participants: Children with a clinical and molecular diagnosis of ABCA4-associated retinopathy without
evidence of macular atrophy.
Methods: The retinal phenotype was characterized by color fundus photography, OCT, fundus auto-
fluorescence (FAF) imaging, electroretinography, and in 2 patients, adaptive optics scanning laser ophthalmos-
copy (AOSLO). Sequencing of the ABCA4 gene was performed in all patients.
Main Outcome Measures: Visual acuity, OCT, FAF, electroretinography, and AOSLO results.
Results: Eight children with ABCA4-associated retinopathy without macular atrophy were identified. Biallelic
variants in ABCA4 were identified in all patients. Four children were asymptomatic, and 4 reported loss of VA.
Patients were young (median age, 8.5 years; interquartile range, 6.8 years) with good visual acuity (median, 0.155
logarithm of the minimum angle of resolution [logMAR]; interquartile range, 0.29 logMAR). At presentation, the
macula appeared normal (n ¼ 3), had a subtly altered foveal reflex (n ¼ 4), or demonstrated manifest fine yellow
dots (n ¼ 1). Fundus autofluorescence identified hyperautofluorescent dots in the central macula in 3 patients, 2
of whom showed a normal fundus appearance. Only 1 child had widespread hyperautofluorescent retinal flecks
at presentation. OCT imaging identified hyperreflectivity at the base of the outer nuclear layer in all 8 patients.
Where loss of outer nuclear volume was evident, this appeared to occur preferentially at a perifoveal locus.
Longitudinal split-detector AOSLO imaging in 2 individuals confirmed that the greatest change in cone spacing
occurred in the perifoveal, and not foveolar, photoreceptors. Electroretinography showed a reduced B-wave-
etoeA-wave ratio in 3 of 5 patients tested; in 2 children, recordings clearly showed electronegative results.
Conclusions: In childhood-onset ABCA4-associated retinopathy, the earliest stages of macular atrophy involve
the parafovea and spare the foveola. In some cases, these changes are predated by tiny, foveal, yellow,
hyperautofluorescent dots. Hyperreflectivity at the base of the outer nuclear layer, previously described as
thickening of the external limiting membrane, is likely to represent a structural change at the level of the foveal
cone nuclei. Electroretinography suggests that the initial site of retinal dysfunction may occur after
phototransduction. Ophthalmology 2018;125:735-746 ª 2018 by the American Academy of Ophthalmology. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Supplemental material available at www.aaojournal.org.Stargardt disease (STGD1; Online Mendelian Inheritance in
Man identifier, 248200) is an autosomal recessive retinal
dystrophy resulting from dysfunction in the photoreceptor-
specific ATP-binding cassette transporter ABCA4. To date,
more than 1000 mutations in ABCA4 have been reported,
associated with phenotypes that include macular, cone, or
coneerod dystrophies.1 Symptoms may develop as early as
the first decade of life, but more commonly occur in the
second or third decade. A minority of individuals
demonstrate a late-onset form of disease in their forties or
fifties that typically spares the central fovea.2 For the youngest
patients, the earliest signs of disease are poorly described, and
despite some understanding of the protein function, the precise
pathogenic mechanisms are yet to be elucidated. Asª 2018 by the American Academy of Ophthalmology
This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/). Published by Elsevier Inc.therapeutic clinical trials either already have commenced
(e.g., stem cell transplantation [clinicaltrials.gov identifier,
NCT01345006], modified vitamin A preparations
[clinicaltrials.gov identifier, NCT02402660], and gene
therapy [clinicaltrials.gov identifier, NCT01367444]) or are
planned, there is a need to identify the site of retinal
dysfunction in early disease and the pattern of progression.
Because most reported cases of STGD1 manifest signs of
macular atrophy at presentation, there is little information
about earlier stages of disease. Herein, we present a series of
patients with molecularly confirmed ABCA4-associated
retinopathy without macular atrophy in which detailed
retinal imaging and functional testing have provided new
insights into the earliest stages of disease.735https://doi.org/10.1016/j.ophtha.2017.11.020
ISSN 0161-6420/17
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Individuals with features suggestive of early ABCA4-associated
retinopathy were recruited prospectively from the pediatric retinal
genetics clinics at Moorfields Eye Hospital (MEH), London, United
Kingdom, and Tokyo Medical Center, Tokyo, Japan. In addition, a
retrospective case note review was performed at MEH to identify
further participants. Those with macular atrophy at presentation were
excluded from this study. Each patient underwent a full clinical ex-
amination, including Snellen or logarithm of the minimum angle of
resolution (logMAR) visual acuity, color vision testing (Hardy Rand
Rittler pseudoisochromatic color plate test, fourth edition), and
dilated fundus examination. Retinal imaging included 35 color
fundus photography (TRC-50DX; Topcon Corp, Tokyo, Japan) and
30 or 55 fundus autofluorescence (FAF)3 imaging (HRA2;
Heidelberg Engineering, Ltd, Heidelberg, Germany). Spectral-
domain OCT imaging was acquired using a Heidelberg HRA2 or
Cirrus HD-OCT 500 (Cirrus; Carl Zeiss Meditec, Ltd, Dublin, CA)
system. Adaptive optics scanning laser ophthalmoscopy (AOSLO)
was carried out on 2 individuals using a custom-built instrument as
previously described.4 Confocal and split-detector (nonconfocal)
image sequences were acquired simultaneously.4e6 Parafoveal lo-
cations were imaged using either a 1 or 1.5 field of view up to 5
eccentricity from the fovea. The images were processed and a
montage was created to illustrate a continuous photoreceptor mosaic.
Retinal function was tested by full-field electroretinography and
pattern electroretinography (PERG), obtained using either gold-foil
electrodes, incorporating the current International Society for Clin-
ical Electrophysiology of Vision (ISCEV) standards in 3 patients, or
with Ganzfeld stimulation and lower eyelid skin electrodes in the 2
youngest children, according to pediatric protocols previously
described.7e9 Genetic testing was performed by targeted exome
sequencing for individuals at MEH (Stargardt/Macular dystrophy
panel, version 3; Casey Eye Institute Molecular Diagnostics Labo-
ratory, Portland, Oregon), or by whole exome sequencing for pa-
tients at Tokyo Medical Center as reported previously.10 Pathogenic
variants were confirmed by Sanger sequencing. This study received
institutional review board approval at Moorfields Eye Hospital,
London, and adhered to the tenets of the Declaration of Helsinki.
Patients or their legal guardians consented to the use of their
clinical data for research purposes.Results
Eight individuals were identified who fulfilled the study criteria.
Six were recruited prospectively and 1 was recruited retrospec-
tively from MEH. Some clinical information for patient 7 has been
published previously.11 The eighth patient was identified from the
Inherited Eye Disease Service, National Hospital Organization,
Tokyo Medical Center, Tokyo, Japan. The clinical and molecular
genetic characteristics for all participants are presented in
Table S1 (available at www.aaojournal.org).
Individuals were young (median age, 8.5 years; interquartile
range, 6.8 years; range, 5e13 years) with good visual acuity
(median, 0.15 logMAR; interquartile range, 0.29 logMAR;
range, 0.14 to 0.3 logMAR) at their initial visit. Four patients
showed symptoms at presentation, reporting a subjective decline in
the quality of their vision. Four children with the best acuity were
asymptomatic. These individuals were identified because of the
presence of peripheral flecks (patient 3) or as a result of having a
more severely affected elder sibling (patients 4, 6, and 8). Color
vision was normal in all individuals tested. In most patients (6/8),
the central macula either appeared normal or showed subtle alter-
ation in the foveal reflex. One patient demonstrated yellow dots at
the fovea (patient 6), whereas a further 2 children demonstrated736these during follow-up (patients 7 and 8). In 7 of 8 patients, the
peripheral retina appeared normal on slit-lamp biomicroscopy.
Patient 3 showed widespread pisciform outer retinal flecks at
presentation that spared the macula.
Autofluorescence Imaging
Fundus autofluorescence abnormalities were evident in all patients,
even when funduscopy results appeared normal. All patients
retained a variable degree of physiologic hypoautofluorescence at
the foveola that qualitatively appeared to be reduced in size when
compared with normal parameters (Fig 1A). The perifoveal retina
was mildly hyperautofluorescent (Fig 1B). With increasing retinal
eccentricity, a further band of hyperautofluorescence was evident
in patients 1, 4, and 5, but less convincingly in patient 2 (Fig
1C). This was broader and more diffuse than the well-defined
ring often observed in patients with other retinal dystrophies. At
their first visit, numerous discrete hyperautofluorescent dots were
present at the fovea in patients 3, 6, and 7 (Fig 2C). Patient 3 was
the only patient to manifest hyperautofluorescent peripheral retinal
flecks at presentation (Fig 2A). No patient demonstrated a complete
loss of foveal autofluorescence, suggesting that the retinal pigment
epithelium (RPE) remained intact at this early stage.
OCT
OCT imaging confirmed that the fourth highly reflective outer retinal
band, thought to represent the RPEeBruch’s membrane12 complex,
was well preserved in all individuals (Fig 3). Moreover, no areas of
increased signal penetrance into the choroid were observed, in
keeping with the absence of RPE atrophy or disease. The most
prevalent finding, observed in all 8 patients, was a marked increase
in reflectivity observed in the outer retina, commencing at the first
highly reflective outer retinal band, thought to represent the
external limiting membrane (ELM), and extending part way
through the outer nuclear layer (ONL; Fig 3). This characteristic
pattern of hyperreflectivity was highly reproducible and was
evident in all patients, with a maximum thickness at the foveola,
reducing nasally and temporally symmetrically, extending into the
peripheral fovea. In most cases, the second highly reflective line
thought to represent the ellipsoid zone was visible below this
abnormally reflective band, but with reduced clarity, suggesting
possible subtle disturbance to the photoreceptor outer segments
(Fig 3). In all patients, focal collapse of the inner retinal layers was
visible because of loss of outer retinal structures (Fig 4). This
appeared to occur at perifoveal loci, rather than at the foveola. The
first sign of outer retinal atrophy seen on OCT imaging appeared
to spare the fovea. In keeping with this, sequential imaging over a
35- and 58-month period in 2 individuals (patients 8 and 7, respec-
tively), demonstrated that the foveolar photoreceptors degenerated
last (Fig 5). For patient 5, progressive loss of foveal outer segments
occurred over a 19-month period, resulting in a broad outer retinal
cavity (Fig 4B and C). Importantly, an intact ELM of physiologic
proportions also was visible. Where the evolution of outer retinal
degeneration was captured on OCT, the temporal perifovea always
seemed to be affected first.
Adaptive Optics Scanning Laser
Ophthalmoscopy
Patients 5 and 6 underwent further retinal imaging of the photo-
receptor layer of their right eyes using a custom-build AOSLO.
Nineteen-month and 13-month follow-up data are shown in
Figures 6 and 7, respectively. Structural changes to the cone
photoreceptor cells of both children were identified. For patient
5, an annulus of nonuniform reflectance was visible, suggesting
Figure 1. Fundus autofluorescence (FAF) changes in childhood-onset
ABCA4-associated retinopathy. A, Patient 2 has a subtle increase in
foveal FAF, while maintaining a small central zone of physiological
hypoautofluorescence. B, In addition to the changes present in (A), a
rhomboid zone of hyperautofluorescence is visible in patient 4. C, Pe-
ripheral macula imaging from patient 1 revealing a more extensive, diffuse
hyperautofluorescent signal. D, A normal pattern of childhood auto-
fluorescence shown for comparison.
Figure 2. Multimodal imaging in patient 3. A, Color fundus photograph
identifying multiple yellow flecks distributed throughout the posterior pole
of both eyes, sparing the peripapillary retina. B, A 488-nm autofluorescence
image revealing that the flecks are highly autofluorescent. In addition,
numerous discrete autofluorescent dots are visible at the fovea, a feature of
disease that usually is not observed. C, The flecks are predominantly
hyporeflective, viewed using near infra-red light, but some appear to have a
highly reflective center. D, OCT image (horizontal line scan through the
foveola) demonstrating hyperreflectivity at the base of the outer nuclear
layer and mild outer retinal degeneration in the temporal macula.
Khan et al  Early ABCA4 Retinopathythe first signs of possible outer segment loss in this area. Confocal
imaging also revealed areas of nonwaveguiding cones in a 2
annulus around the foveola, with relative sparing of the central
foveal cones, which appeared more contiguous and uniformly
reflective than their parafoveal neighbors. The split detector-
derived images also revealed abnormal, enlarged cone inner seg-
ments. The foveal center was relatively spared of these changes,
because the cone inner segments remain tightly packed. This re-
gion of disturbance to the cone outer segments correlates well withthe area of hyperautofluorescence visible on FAF imaging (Fig 6).
Patient 6 showed the same irregular appearance of the outer
segments centrally over a 13-month period, but with fewer
apparent dark spaces of nonwaveguiding cones. The inner segment
cone mosaic also revealed similar changes at this stage, because the
parafoveal cones appeared enlarged compared with those of sur-
rounding areas. Patients 5 and 6 both showed a similar pattern of
degeneration over the course of their follow-up that seemed to
affect the parafoveal photoreceptor mosaic selectively while
sparing the foveal region.737
Figure 3. OCT images from 4 patients. Representative horizontal line scans through the foveola are shown for all patients. In all cases, there is a well-
defined region of hyperreflectivity extending superiorly from the first highly reflective OCT line, the optical correlate of the external limiting mem-
brane. It is maximally thick at the foveola, and reduces exponentially with increasing retinal eccentricity. In AeD the ellipsoid zone (second highly
reflective outer retinal line) also is readily visible.
Figure 4. OCT images highlighting patterns of early foveal degeneration. Horizontal line scans through the foveola. A, Patient 4 with early temporal
collapse bilaterally. The integrity of ellipsoid zone has been breached just temporal to the foveola. B, C, Imaging in patient 5 demonstrating the same
changes nasally and temporally (B) at baseline and (C) 19 months later.
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Figure 5. The evolution of macular atrophy in childhood-onset ABCA4-associated retinopathy. Sequential OCT (horizontal line scans through the
foveola) in (upper) patient 7 and (lower, with decimalized visual acuity) patient 8. The earliest structural change appears to be hyperreflectivity at the base of
the outer nuclear layer (patient 8, baseline), associated with near normal vision. Over the next 2 years, parafoveal outer retinal atrophy developed (yellow
arrowheads), whereas the foveola is relatively spared of these changes (yellow horizontal line baseline images from patients 8 and 7). By month 35, the
ellipsoid zone at the foveola clearly is degenerating, associated with a drop in acuity (asterisk, patient 8). LE ¼ left eye; RE ¼ right eye; Vd ¼ visual acuity
dexter; Vs ¼ visual acuity sinister.
Khan et al  Early ABCA4 RetinopathyElectroretinography
Pattern and full-field electroretinography were performed in 5 of 8
patients (Fig 8). In 3 of 5 patients (patients 2, 5, and 7), the PERGP50
components were subnormal, indicatingmacular dysfunction. Of the
2 patients with normal PERG results, one was aware of reduced
central vision, whereas the other was asymptomatic. Four of 5
patients showed full-field electroretinography evidence of general-
ized retinal dysfunction despite a normal peripheral retinal appear-
ance on biomicroscopy. Patient 7 showed a reduction in the dark-
adapted (DA) strong flash (DA 10.0) electroretinography A-wave
and delay and reduction in the light-adapted (LA) 30-Hz flicker
electroretinography and LA 3.0 single-flash electroretinography A-
and B-waves, consistent with a coneerod dystrophy. In 2 other
patients, DA 10.0 electroretinography results showed normal A-waves, but electronegative waveforms (B-to-A ratio, <1; patients 1
and 2) or a borderline B-to-A ratio (patient 4); there was additionally
a low B-to-A ratio in the LA 3.0 electroretinography results in pa-
tients 1 and 4 (Fig S1, available at www.aaojournal.org). The
electroretinography results in these 3 patients suggest generalized
retinal dysfunction occurring after phototransduction involving the
rod (patient 2) or both cone and rod systems (patients 1 and 4).Discussion
More than 100 years ago, Stargardt13 described a series of
patients with hereditary visual loss and macular atrophy.
Since then, and despite many significant advances, the739
Figure 6. Spectrum of foveal structure shown with (AeD) OCT (scale bar, 200 mm), (E, F) fundus autofluorescence (scale bar, 1000 mm), and (GeJ)
adaptive optics scanning laser ophthalmoscopy (AOSLO; scale bar, 200 mm) at baseline (upper panel) and 19 months later (lower panel) for patient 5.
Arrows denote outer edges of the region imaged on AOSLO. Vertical scan (A) and horizontal scan (B) demonstrating initial hyperreflectivity at the base of
the outer nuclear layer and parafoveal outer retinal degeneration. Vertical scan (C) and horizontal scan (D) detail the evolution of outer retinal atrophy and
parafoveal cavitation. E, F, Fundus autofluorescence over the same period. Adaptive optics scanning laser ophthalmoscopy imaging of the foveal cones at
baseline (G, confocal; I, split-detector) and 19 months later (H, confocal; J, split-detector). G, H, Confocal imaging revealing areas of nonwaveguiding
cones evident from both time points, predominantly in a parafoveal location, suggesting cell loss from baseline visit.H, However this is more apparent at the
19-month follow-up visit. Split-detector images show the diameter increase of inner segments and the increase in cell spacing over this period, again in a
parafoveal location.
Ophthalmology Volume 125, Number 5, May 2018sequence of events that ultimately result in RPE and
photoreceptor cell death remains elusive. In an attempt to
address this, we chose to study the earliest stages of
STGD1, examining a cohort of children before the
development of macular atrophy. Using complimentary
structural and functional tests (OCT, FAF, AOSLO,
electroretinography), we have been able to identify a
number of novel characteristics.
One of the earliest structural changes observed was in the
ONL, evident on the OCT images of all patients. The OCT
images revealed an obvious increase in reflectivity extending
internally from the line thought to be the optical correlate of
the ELM.14 The thickness of this change was at a maximum
at the foveola and appeared to decline monotonically as a
function of eccentricity to become invisible at the edge of
the foveal avascular zone (as defined by the near-infrared
reflectance images). Reflectivity within the inner (most
vitreal) ONL, a region where Henle fibers reside, always
remained unaffected. This uncommon OCT abnormality has
been termed ELM thickening, presumably because of the
increased reflectivity appearing to be continuous with the
ELM.11,15e18 The ELM represents the adherens junctions
between Müller cells, or Müller cells and photoreceptor inner
segments, and it seems improbable that thickening of this
structure would occur as the first sign of STGD1.19 We now
suggest an alternative hypothesis: that the identified changes
are the result of pathologic disruption within the outer
lamella of the ONL, specifically in the cones. Within the
ONL, cone photoreceptor nuclei have defined spatial
distribution, being most numerous and tightly packed at
the fovea and less densely packed, residing more closely
approximated to the ELM, in the perifoveal retina (Fig
9).20 In contrast, rod nuclei are thought to be less spatially
restricted and are distributed throughout the entire740thickness of the ONL.20 This arrangement of cone and rod
nuclei has been known for more than a century and
originally was described by Ramón y Cajal and
Swanson.21 More recent studies have shown the same
distribution in murine and primate retinas.22,23 OCT imag-
ing in this case series confirmed that the ellipsoid zone is still
evident in early disease, but it appears to be reduced quali-
tatively in intensity, suggesting that in addition to the
changes to the ONL, there are subtle outer segment patho-
logic features. Finally, increased ONL reflectivity seems to
be a transient phenomenon, sustained only as long as the
ONL volume is preserved, whereas the line representing the
ELM remains preserved at the same stage (Fig 6). Indeed,
others have commented on the robust nature of the ELM,
even in patients with advanced disease.15
Sequential imaging provided further insight into the
precise sequence of events leading to macular atrophy.
Where significant numbers of photoreceptor nuclei were
lost, OCT-documented collapse of the inner retinal layers
into ONL seemed to occur preferentially at perifoveal loci,
sparing the foveola, at least initially (Figs 4 and 5). This
pattern of degeneration also was evident using the split-
detector AOSLO, where the greatest increase in cone
spacing occurred in the parafoveal region, with relative
sparing of the foveolar cones (Figs 5 and 6). However,
quantification of the AOSLO changes was not possible,
both because of the difficult nature of imaging young
patients and the size and dense packing of foveal cones at
baseline visits, which were comparable with those of
unaffected individuals. OCT determined ONL thickness
measurements therefore may be the current biomarker of
choice for monitoring this group of patients. Regardless of
the imaging technique used, foveolar-sparing retinal
degeneration was a particularly unexpected finding, because
Figure 7. Foveal structure shown with (A, B) OCT and (C, D) adaptive optics scanning laser ophthalmoscopy at baseline (left hand column) and 13
months later (right hand column) for patient 6. Scale bars, 200 mm. Arrows denote outer edges of the region imaged on adaptive optics scanning laser
ophthalmoscopy (AOSLO). Both (C, D) confocal and (E, F) split-detector imaging are presented. Confocal imaging reveals only subtle changes over this
period, manifested by an increase in dark areas of nonwaveguiding cones. Split-detector imaging shows a more evident change in parafoveal cone structure
over 13 months, with a marked increase in the diameter of cone inner segments.
Khan et al  Early ABCA4 Retinopathyfoveal involvement usually is the hallmark of childhood-
onset STGD1. However, if individuals are imaged with
sufficient resolution at an early stage of disease, foveola
sparing may be the rule rather than the exception. Because
childhood-onset disease usually evolves rapidly, the best
chance of identifying this stage of disease is likely to be
provided by examining siblings of affected children, or less
commonly as observed here, when peripheral flecks are
detected on a routine eye examination at a time when visual
acuity is preserved temporarily. Early parafoveal involve-
ment also is a notable feature of another STGD1 phenotype,
a late-onset adult form of STGD1 in which foveal sparing iscommon.24 Although childhood-onset disease with early
foveal involvement and adult-onset foveal-sparing disease
are likely to represent 2 extremes of the STGD1 severity
spectrum, both seem to share a similar pattern of retinal
degeneration and differ only in the rate at which their dis-
ease progresses. Finally, if foveolar-sparing disease is the
norm, one could counter this assertion arguing that a specific
subgroup of patients exist where degeneration begins at the
fovea: those with outer retinal cavitation.25 High-resolution
imaging in patient 5 demonstrated that even when photo-
receptors are not visible using OCT, they can be detected
using AOSLO, and that even at this time, residual cones are741
Figure 8. Full-field electroretinography and pattern electroretinography in children with early-stage ABCA4-associated retinopathy. Recordings obtained
with lower eyelid skin electrodes are shown for (A) patient 1 and (E) patient 2 and are compared with representative normal traces obtained with the same
recording system (B and F, respectively). Recordings obtained with gold-foil corneal electrodes are shown for (C) patient 5 and (G) patient 7 and are
compared with representative normal traces obtained with the same type of recording system (D and H, respectively). Dark-adapted (DA) responses are
shown for flash strengths of 0.01 and 10.0 cd.s.me2 (DA, 0.01; DA, 10.0) and for light-adapted (LA) electroretinography results for flash strength of 3.0
cd.s.m2 (LA 3.0; 30 Hz and 2 Hz). Pattern electroretinography (PERG) is recorded to an alternating checkerboard. There is a reduced B-to-A ratio
(electronegative results) in recordings from (A) patient 1 and (E) patient 2 consistent with dysfunction that occurs after phototransduction involving the
(A) rod and cone or (E) rod system. Full-field electroretinography results (C) are normal for patient 5 and (G) show evidence of a coneerod dystrophy in
patient 7. Pattern electroretinography P50 reduction indicates macular dysfunction for patients 2, 5, and 7. All recordings showed a high degree of
interocular symmetry and are illustrated for 1 eye only. Note the prestimulus delay in all single flash recordings with the exception of (H). For clarity, broken
lines replace blink artefacts.
Ophthalmology Volume 125, Number 5, May 2018still most numerous at the foveola (Fig 6). Our findings
therefore suggest that therapeutic interventions are likely
to work best in childhood-onset ABCA4-associated reti-
nopathy if given very early, although it may be challenging
to recruit such patients for clinical trials until convincing
safety and efficacy data are available in adults.
Autofluorescence imaging additionally contributes novel
information. In keeping with the hypothesis that perifoveal742disease occurs first, foveolar autofluorescence characteristics
were relatively well preserved, because all individuals retained
a degree of physiological hypoautofluorescence. This suggests
that structures important for imparting these characteristics, the
RPE and macular pigments within Henle fibre layer, also
remain relatively intact.26 Fundus autofluorescence imaging
also was able to characterize 2 discrete patterns of
hyperautofluorescence: classical pisciform flecks that do not
Figure 8. (continued).
Khan et al  Early ABCA4 Retinopathyencroach on the foveola and tiny discrete dots that never extend
outside the foveola (Fig 2). Although both lesions eventually
evolve to outer retinal atrophy, they may do so at different
rates. Whereas the larger outer retinal deposits are visible
using OCT, the precise location of the smaller foveal lesions
remains unknown. Although the present work cannot answer
this question definitively, it is tempting to speculate thatFigure 9. Schematic retinal tomograph highlighting the location of
photoreceptor nuclei. Cone nuclei lie within the basal outer nuclear layer
(ONL), closely opposed to the external limiting membrane (ELM), except
at the foveola, where they are most numerous. Rod nuclei (RN) are less
spatially restricted, distributed throughout the entire ONL. The hyper-
reflectivity visible using OCT seems to correlate directly with the location
of cone nuclei (CN). ILM ¼ internal limiting membrane; RPE ¼ retinal
pigment epithelium.these characteristics may result from differences in
photoreceptor retinal metabolism, via an intraretinal pathway
involving Müller cells for cones or via the RPE for rods.27 If
true, this would mean that the tiny hyperautofluorescent dots
are likely to be intraretinal, whereas the larger flecks are
present in the RPEephotoreceptor outer segments. This is in
keeping with prior studies that have identified
autofluorescent material in cone inner segments and in
Müller cell processes, as well as more conventionally in the
RPE.28,29 Our OCT and FAF data also support the hypothe-
sis that cone photoreceptor dysfunction is intrinsic and not
secondary to RPE failure, concurring with previous animal
studies.30 In the absence of ABCA4 flippase activity, toxic
bisretinoids accumulate in the photoreceptor outer segment,
which occurs to a greater extent in mice with a cone-
dominant (Abca4//Nrl/) compared with a rod-dominant
(Abca4/) background.30 Not only is bisretinoid production
higher in cones than in rods, cones are also slower to clear
this, transferring less of this toxic product to the RPE.30
Therefore, it is unsurprising that these biochemical
differences are reflected in the clinical signs.
The electroretinography findings in 4 of 5 children indicated
generalized retinal dysfunction, including 3 patients with743
Ophthalmology Volume 125, Number 5, May 2018electronegative findings, in keeping with a locus of dysfunction
occurring after phototransduction. Subnormal electroretinog-
raphy B-to-A ratios and electronegative findings (B-to-A ratio
less than 1.0) have been reported in a wide range of inherited
retinal diseases, but not consistently in STGD1.31 A rare
published example was in an 8-year-old boy with early-onset
panretinal STGD1.32 Because all children in the current study
had mild or early disease, it is postulated that the
electroretinography findings may arise from metabolically
stressed photoreceptors, before cell death, with the most
sensitive physiologic processes being the most vulnerable.
Phototransduction and outer segment hyperpolarization may
remain relatively well preserved, consistent with
electroretinography A-wave preservation, whereas inner
segment physiology, in particular metabolically demanding
processes such as neurotransmitter release from the
presynaptic terminal, may be compromised. Disruption of
neurotransmitter release would impair signaling to both the
rod-on and cone-on and -off bipolar cells, largely responsible
for generation of DA and LA electroretinography B-waves,
respectively. The same mechanism also may contribute to the
electroretinography electronegativity observed in some other
primary photoreceptor dystrophies.33 Alternative explanations
for a low B-to-A ratio include retraction of photoreceptor
synapses and de novo synapse formation, with other cells in
the inner retina leading to disrupted signaling to the bipolar cells.
Finally, 2 disease-associated alleles were identified in all
patients in this series, highlighting the prior observation that
genetic testing in childhood-onset STGD1 has a high chance
of success.17,34 Again in keeping with previous reports is the
identification of the allele c.5461e10T/C, which recurred
here in 2 of 8 patients. This variant now has been identified
consistently in childhood-onset cohorts, in trans with
missense variants, as well as in association with late-onset
foveal-sparing disease, where the second allele often re-
mains undetected.2,17,34,35 The most recent evidence sug-
gests that this variant is itself pathogenic and not necessarily
in linkage disequilibrium with an as-yet undiscovered
disease-causing allele.36,37 To the best of our knowledge,
the same combination of ABCA4 alleles has not been re-
ported to cause mild (late-onset, foveal-sparing) and severe
disease.
This work represents the first detailed description of the
earliest anatomic changes that occur in childhood-onset
ABCA4-associated retinopathy. Rather than using an arbi-
trary cutoff based on patient age, we defined the earliest
stages by the absence of clinically apparent outer retinal
atrophy. As a result, most individuals were minimally
symptomatic. Using this approach, we have been able to
highlight novel features associated with early photoreceptor
degeneration. Why the foveola is relatively spared in the
initial stages of disease is yet to be determined, although one
may speculate that this relates to structural or functional
differences between foveal and parafoveal cones. These
findings will facilitate detection of STGD1 in its mildest
form and will provide vision researchers with novel insights
into the first stages of disease. Our hope is that this work
also advances the identification and verification of sensitive
biomarkers necessary for monitoring patient outcomes in
future therapeutic trials.744References
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michaelides@ucl.ac.uk.Pictures & PerspectivesLeukemic Optic Nerve Infiltration Responds to Radiation and Blinatumomab
A 52-year-old man with a history of Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in remission presented
with decreased vision in the right eye (OD) and headache. His visual acuity was count fingers OD and 20/20 left eye (OS). Fundoscopic
examination revealed bilateral optic disc edema (Fig 1A and B). He was diagnosed with leukemic infiltration of the optic nerves. Treatment
consisted of urgent radiotherapy and Blinatumomab, an anti-CD19 antibody that redirects T cells to enhance lysis of tumor cells. Six weeks
after treatment, the visual acuity improved to 20/50 OD and remained 20/20 OS (Fig 1C and D). (Magnified version of Fig 1AeD is
available online at www.aaojournal.org.)
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